Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2
Summary: N-type voltage-gated calcium (CaV) channels mediate Ca2+ influx at presynaptic terminals in response to action potentials and play vital roles in synaptogenesis, release of neurotransmitters, and nociceptive transmission. Here, we elucidate a cryo-electron microscopy (cryo-EM) structure of...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-11-01
|
| Series: | Cell Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721014042 |
| _version_ | 1819010211088695296 |
|---|---|
| author | Yanli Dong Yiwei Gao Shuai Xu Yuhang Wang Zhuoya Yu Yue Li Bin Li Tian Yuan Bei Yang Xuejun Cai Zhang Daohua Jiang Zhuo Huang Yan Zhao |
| author_facet | Yanli Dong Yiwei Gao Shuai Xu Yuhang Wang Zhuoya Yu Yue Li Bin Li Tian Yuan Bei Yang Xuejun Cai Zhang Daohua Jiang Zhuo Huang Yan Zhao |
| author_sort | Yanli Dong |
| collection | DOAJ |
| description | Summary: N-type voltage-gated calcium (CaV) channels mediate Ca2+ influx at presynaptic terminals in response to action potentials and play vital roles in synaptogenesis, release of neurotransmitters, and nociceptive transmission. Here, we elucidate a cryo-electron microscopy (cryo-EM) structure of the human CaV2.2 complex in apo, ziconotide-bound, and two CaV2.2-specific pore blockers-bound states. The second voltage-sensing domain (VSD) is captured in a resting-state conformation, trapped by a phosphatidylinositol 4,5-bisphosphate (PIP2) molecule, which is distinct from the other three VSDs of CaV2.2, as well as activated VSDs observed in previous structures of CaV channels. This structure reveals the molecular basis for the unique inactivation process of CaV2.2 channels, in which the intracellular gate formed by S6 helices is closed and a W-helix from the domain II–III linker stabilizes closed-state inactivation. The structures of this inactivated, drug-bound complex lay a solid foundation for developing new state-dependent blockers for treatment of chronic pain. |
| first_indexed | 2024-12-21T01:08:39Z |
| format | Article |
| id | doaj.art-3f815d9bfcb64a66b3a15ec8b32f971b |
| institution | Directory Open Access Journal |
| issn | 2211-1247 |
| language | English |
| last_indexed | 2024-12-21T01:08:39Z |
| publishDate | 2021-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Cell Reports |
| spelling | doaj.art-3f815d9bfcb64a66b3a15ec8b32f971b2022-12-21T19:20:58ZengElsevierCell Reports2211-12472021-11-01375109931Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2Yanli Dong0Yiwei Gao1Shuai Xu2Yuhang Wang3Zhuoya Yu4Yue Li5Bin Li6Tian Yuan7Bei Yang8Xuejun Cai Zhang9Daohua Jiang10Zhuo Huang11Yan Zhao12National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaState Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaLaboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China; Corresponding authorState Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China; IDG/McGovern Institute for Brain Research, Peking University, Beijing 100871, China; Corresponding authorNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China; State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China; Corresponding authorSummary: N-type voltage-gated calcium (CaV) channels mediate Ca2+ influx at presynaptic terminals in response to action potentials and play vital roles in synaptogenesis, release of neurotransmitters, and nociceptive transmission. Here, we elucidate a cryo-electron microscopy (cryo-EM) structure of the human CaV2.2 complex in apo, ziconotide-bound, and two CaV2.2-specific pore blockers-bound states. The second voltage-sensing domain (VSD) is captured in a resting-state conformation, trapped by a phosphatidylinositol 4,5-bisphosphate (PIP2) molecule, which is distinct from the other three VSDs of CaV2.2, as well as activated VSDs observed in previous structures of CaV channels. This structure reveals the molecular basis for the unique inactivation process of CaV2.2 channels, in which the intracellular gate formed by S6 helices is closed and a W-helix from the domain II–III linker stabilizes closed-state inactivation. The structures of this inactivated, drug-bound complex lay a solid foundation for developing new state-dependent blockers for treatment of chronic pain.http://www.sciencedirect.com/science/article/pii/S2211124721014042CaV2.2closed-state inactivationchannel blockerziconotideN-typevoltage-gated calcium channel |
| spellingShingle | Yanli Dong Yiwei Gao Shuai Xu Yuhang Wang Zhuoya Yu Yue Li Bin Li Tian Yuan Bei Yang Xuejun Cai Zhang Daohua Jiang Zhuo Huang Yan Zhao Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 Cell Reports CaV2.2 closed-state inactivation channel blocker ziconotide N-type voltage-gated calcium channel |
| title | Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 |
| title_full | Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 |
| title_fullStr | Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 |
| title_full_unstemmed | Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 |
| title_short | Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2 |
| title_sort | closed state inactivation and pore blocker modulation mechanisms of human cav2 2 |
| topic | CaV2.2 closed-state inactivation channel blocker ziconotide N-type voltage-gated calcium channel |
| url | http://www.sciencedirect.com/science/article/pii/S2211124721014042 |
| work_keys_str_mv | AT yanlidong closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT yiweigao closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT shuaixu closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT yuhangwang closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT zhuoyayu closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT yueli closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT binli closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT tianyuan closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT beiyang closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT xuejuncaizhang closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT daohuajiang closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT zhuohuang closedstateinactivationandporeblockermodulationmechanismsofhumancav22 AT yanzhao closedstateinactivationandporeblockermodulationmechanismsofhumancav22 |